CORTESI, Paolo Angelo; PAOLICELLI, Damiano; CAPOBIANCO, Marco; COZZOLINO, Paolo; MANTOVANI, Lorenzo Giovanni. The Value and Sustainability of Ocrelizumab in Relapsing Multiple Sclerosis: A Cost-Effectiveness and Budget Impact Analysis. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 20, n. 1, 2019. DOI: 10.7175/fe.v20i1.1435. Disponível em: https://provafe.seedstm.com/index.php/FE/article/view/1435. Acesso em: 23 jul. 2025.